Dr. Maria Castro was interviewed by Gill Eapen who developed the science/medicine podcast called Scientific Sense. YouTube: https://youtu.be/HYkvkbkAGsE Spotify: Prof. Maria Castro of University of Michigan on Brain Cancer by Scientific Sense ® (spotify.com)
Gene therapy for brain tumor shows promising early results in humans. Read more here
Finalist in the University of Michigan Engineering 3 Minute Thesis Competition. The goal of Three Minute Thesis (3MT®) competition is to stimulate students to develop skills for effectively communicating their research in language appropriate for a non-specialist audience. September 22, 2023.
“Two Argentine scientists in the United States lead advances against a type of brain tumor” by Victor Ingrassia. Read more here.
Wednesday, September 27 at the Michigan! Join us for a pre-film panel discussion at 6:00 PM with Michelle Hastings, Ph.D.; Maria G. Castro, Ph.D.; Christiane Wobus, Ph.D.; Henry Paulson, M.D., Ph.D.; Peter Todd, M.D., Ph.D.; and moderated by Nils G. Walter, Ph.D. Film screening will begin at 7:00 PM. The story of a doctor’s extraordinary work in the Sixties with a group of catatonic patients…
Congratulations Dr. Syed Faisal, Dr. Maria G. Castro and Dr. Pedro R. Lowenstein on your publication “Adenovirus-mediated combined cytotoxic and immune-stimulatory gene therapy using dual-vector Ad-hCMV-TK and Ad-hCMV-Flt3L: translational explorations from rodents to glioma patients” being accepted in Molecular Therapy.
Dr. Haase has accepted a position as a Bioinformatics Scientist in the Integrative Program for Biological and Genome Sciences (IBGS) at The University of North Carolina at Chapel Hill.
Dr. Castro will be Keynote Speaker at the Finnish Brain Tumor Research Association (FIBTRA) Annual Symposium 8/31/2023-9/1/2023 in Kuopio, Finland. The title of Dr. Castro’s presentation is “Epigenetic Remodeling within Glioma Cells Impacts Myelopoiesis and the Response to Immunotherapies: Clinical Implications”. Click here to register .
Congratulations to Dr. Pedro Lowenstein Dr. Maria G. Castro, Dr. Maria Luisa Varela, Dr. Faisal Syed, and Molly West on publication “A non-randomized, open-label, dose-finding, first-in-human trial of combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma” being accepted in The Lancet Oncology.